Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Dev Behav Pediatr. 2013 Sep;34(7):508–522. doi: 10.1097/DBP.0b013e31829d1f20

Table 1.

Outcome Measures Used in Prior Published Trials in FXS

Trial (First author, Year published (reference)) Design1 N2 Measures Used3 Measures Reliable4 Measures Change- Sensitive5
Behavioral Cognitive Biomarker
High-dose folate, (Hagerman, 1986 (112)) DB, PC, XO 25 CARS, AutBC PPVT, TOLD, IQ ND None
Methylphenidate, (Hagerman 1988 (113)) DB, PC, XO 15 Conner Scales ND Conner
Folinic acid (Strom 1992 (114)) DB, PC, XO 21 CTRS, CPRS ACTeRS VABS, PPVT ND None
Methylphenidate, Amphetamine salts, (Hagerman 2002 (115)) OL 19 EDR ND EDR
CX516, (Berry-Kravis 2006 (116)) DB, PC 48 ABC, SNAPIV, VAS, CGI, CARS, GARS, ADOS RBANS, CELF, PLS-4, PPVT, TVPS, W- JMem, IVA, VABS PPVT, PLS-4, RBANS (LR, LL, DS, SM subtests), W-JMem, SNAPIV, ADOS Comm, CARS, ABC Subscales, VAS Behavior None
N-acetyl-carnitine (Torrioli 2008 (117)) DB, PC, XO 63 CGI-T, CGI-P VABS, WISC ND CGI-T, CGI-T, VABS
Lithium, (Berry-Kravis 2008 (80)) OL 15 ABC, VAS, CGI RBANS, PPVT, CFXCPT, NEPSY Tower, NVALT, Card Task, VABS ERK, Eye Tracking, Auditory Filtering, Autonomic Testing – RSA, HR, HRV CFXCPT (in concurrent study) ABC, VAS, CGI, RBANS (LL), VABS-L, ERK
Fenobam, (Berry- Kravis 2009 (96)) OL 12 CFXCPT PPI PPI (concurrent study) PPI
Donepezil, (Fung 2012, Kesler 2009, (73,111)) OL ABC, CBCL CNT, HVLT MRS
Memantine, (Erickson 2009 (118)) OL 6 ABC, CGI, ADHDRS-IV, SRS ND None significant
Valproic acid, (Torrioli 2010 (119)) OL 10 CTRS, CPRS, CGI, SNAPIV, K-SADS-PL VABS FMR1 re- activation ND CPRS-R
Minocycline, (Paribello 2010 (120)) OL 20 ABC, CGI, VAS RBANS, PPVT, NVALT ND ABC, CGI, VAS, RBANS (LL, SM)
Aripiprazole, (Erickson 2010 (121)) OL 15 ABC, CGI, CY-BOCS ND ABC, CY-BOCS, CGI
Riluzole, (Erickson 2011 (90)) OL 6 CY-BOCS, CGI ADHDRS-IV, ABC, SRS PPVT ERK ND ADHDRS-IV, ERK
AFQ056, (Jacquemont 2011 (76)) DB, PC, XO 30 ABC, RBS, CGI, VAS, SRS KiTAP, RBANS, PPVT ERK, Eye Tracking, PPI, FMR1 methylation, FMR1 mRNA ND CGI, ABC, RBS, VAS (in fully methylated group)
Oxytocin, (Hall 2012 (122)) DB, PC 8 Eye tracking, cortisol, Autonomic Testing – RSA, HR, HRV ND Eye tracking, cortisol
Arbaclofen, (Berry- Kravis 2012 (72)) DB, PC, XO 62 ABC, RBS, VAS, CGI, SRS, CASI, ADHDRS-IV RBANS, PPVT, VABS, SB5- WM PPI, APP ABC-SW, VABS- P/L, CGI, VAS
Acamprosate, (Erickson 2012 (123)) OL 12 ABC, CGI, SRS, CASI, ADHDRS-IV PPVT, VABS APP APP, ABC, CGI, SRS, ADHDRS-IV
1

DB=Double-blind, PC=Placebo-controlled, XO=Crossover, OL=Open label

2

Number of subjects in trial

3

Adaptive measures are included in the Cognitive section. Abbreviations for measures as follows: ABC=Aberrant Behavior Checklist-Community Edition (SW=Social Withdrawal Subscale), ACTeRS=ADD-H Comprehensive Teacher’s Rating Scales, ADHDRS-IV=ADHD Rating Scale IV, ADOS=Autism Diagnostic Observation Scale, APP=Amyloid precursor protein, AutBC=Autism Behavior Checklist, Card Task=Card Task Test of Visual Sequential Memory, CARS=Childhood Autism Rating Scale, CASI=Childhood Anxiety Sensitivity Index, CBCL=Child Behavior Checklist, CELF=Clinical Evaluation of Language Skills, CFXCPT=Carolina Project Fragile X Continuous Performance Test, CGI=Clinician Global Impression, CGI-P=Conner Global Index for Parents, CGI-T=Conner Global Index for Teachers, CNT+=Contingency Naming Task, CPRS=Conner Parent Rating Scale, CTRS=Conner Teacher Rating Scale, CY-BOCS =Children’s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders, EDR=Electrodermal responses, ERK=ERK-related kinase activation rate, GARS=Gillam Autism Rating Scale, HR=Heart Rate, HRV=Heart Rate Variability, HVLT=Hopkins Verbal Learning Test, IVA=Integrated Visual-Auditory CPT, KiTAP=Tests of Attentional Performance for Children, K-SADS PL=Kiddie Schedule for Affective Disorder and Schizophrenia for School Age Children - Present and Lifetime Version, NVALT=Non-Verbal Associative Learning Task, PLS-4=Preschool Language Scale – Version 4, PPI=Prepulse Inhibition, PPVT=Peabody Picture Vocabulary Test, RBANS=Repeatable Battery for the Assessment of Neurological Status (LL=List Learning, SM=Story Memory, DS=Digit Span, LR=List Recall Subtests), RBS=Repetitive Behavior Scale, RSA=Respiratory Sinus Arrythmia, SB5-WM=Stanford-Binet Version 5 Working Memory Index, SNAPIV=Swanson, Nolan, and Pelham Questionaire for ADHD, SRS=Social Responsiveness Scale, TOLD=Test of Language Development, TVPS=Test of Visual Perceptual Skills, VABS=Vineland Adaptive Behavior Scale (P/L=Play and Leisure Subscale), VAS=Visual Analog Scale, W-JMem=Woodcock-Johnson Memory for Words

4

Reliability not assessed in all trials, data presented includes only those analyzed that had ICC or weighted Kappa>0.8 on test retest

5

Measures change-sensitive in trial are presented, it must be recognized that lack of change-sensitivity in the absence of a drug effect does not rule out change sensitivity for the measure, change sensitivity may be exaggerated or reported as present when measuring only placebo effect in open-label studies, if just a subtest was change-sensitive-subtest name given in parethesis